BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.59
-0.24 (-3.07%)
At close: Dec 5, 2025, 4:00 PM EST
7.62
+0.03 (0.40%)
After-hours: Dec 5, 2025, 7:10 PM EST
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 580 employees as of December 31, 2024. The number of employees increased by 44 or 8.21% compared to the previous year.
Employees
580
Change (1Y)
44
Growth (1Y)
8.21%
Revenue / Employee
$1,034,166
Profits / Employee
-$15,136
Market Cap
1.60B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCRX News
- 2 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 days ago - BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition - GlobeNewsWire
- 11 days ago - BioCryst Pharmaceuticals, Inc. (BCRX) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO® (berotralstat) - GlobeNewsWire
- 4 weeks ago - BioCryst to Present at Upcoming Investor Conference - GlobeNewsWire
- 4 weeks ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting - GlobeNewsWire